P-1184. Efficacy and Safety of Imipenem/Cilastatin/Relebactam (IMI/REL) in Treating Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia: A Systematic Literature Review of Randomized Control Trials

Authors

Institutions

Publication Details

Journal
Open Forum Infectious Diseases
Published
2026-01-01
DOI
https://doi.org/10.1093/ofid/ofaf695.1377
Primary Topic
Nosocomial Infections in ICU
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

P-1184. Efficacy and Safety of Imipenem/Cilastatin/Relebactam (IMI/REL) in Treating Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia: A Systematic Literature Review of Randomized Control Trials

Emre Yücel, Carolyn A. Cameron, Sachin Kumar, Shalini Bagga et al.
Open Forum Infectious Diseases
Nosocomial Infections in ICU
article

P-1184. Efficacy and Safety of Imipenem/Cilastatin/Relebactam (IMI/REL) in Treating Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia: A Systematic Literature Review of Randomized Control Trials

Emre Yücel, Carolyn A. Cameron, Sachin Kumar, Shalini Bagga, Vaneet Pal Kaur Khurana, Prashant Soni
article en

Abstract

No abstract available for this paper.
Open Forum Infectious DiseasesVol. 13(Supplement_1)
Merck & Co., Inc., Rahway, NJ, USA (United States) (US), California Historical Society (US), MSD (Australia) (AU)
Good health and well-being
Openalex Percentile: Top 91%
Nosocomial Infections in ICU
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.